Not finding it? Sign in to also search OpenAlex live.
-
Internet-based problem solving therapy improves depressive and dialysis related physical symptoms in hemodialysis patients under 65 years of age: A post-hoc secondary subgroup analysis of a cluster randomized controlled trial
Debbie Zittema, Robbert W. Schouten, Els Nadort, Rosa E. Boeschoten, Yves F.C. Smets, Prataap Chandie Shaw, +11 more
0citations -
PROTECT Subgroup Analysis: Clinical Benefits of Sparsentan (SPAR) vs. Irbesartan (IRB) in Patients with IgAN Who Have Proteinuria above and below 1 g/g2024 Journal of the American Society of Nephrology article Medicine Renal Diseases and Glomerulopathies
Laura Ann Kooienga, Hernán Trimarchi, Jürgen Floege, Priscila Preciado, Jai Radhakrishnan
0citations -
No difference in effects of ‘PACE steps to success’ palliative care program for nursing home residents with and without dementia: a pre-planned subgroup analysis of the seven-country PACE trial
Rose Miranda, Tinne Smets, Nele Van Den Noortgate, Jenny Theodora van der Steen, Luc Deliëns, Sheila Alison Payne, +6 more
10citations -
A synthesis and subgroup analysis of the eosinophilic esophagitis tissue transcriptome2023 Journal of Allergy and Clinical Immunology article Medicine Eosinophilic Esophagitis Open access
Justin Jacobse, Rachel E. Brown, Frank L. Revetta, Michael Fredrick Vaezi, Matthew A. Buendia, Christopher S. Williams, +5 more
23citations -
Cardiovascular outcomes and safety with linagliptin, a dipeptidyl peptidase‐4 inhibitor, compared with the sulphonylurea glimepiride in older people with type 2 diabetes: A subgroup analysis of the randomized CAROLINA trial
Mark Andrew Espeland, Richard E. Pratley, Julio Rosenstock, Takashi Kadowaki, Yutaka Seino, Bernard Zinman, +7 more
33citations -
Solriamfetol for the Treatment of Excessive Daytime Sleepiness in Participants with Narcolepsy with and without Cataplexy: Subgroup Analysis of Efficacy and Safety Data by Cataplexy Status in a Randomized Controlled Trial
Yves A Dauvilliers, Colin Michael Shapiro, Geert Mayer, Gert Jan Lammers, Hélène A. Emsellem, Giuseppe Plazzi, +5 more
18citations -
Improved assessment of coronary artery disease in obese patients with flurpiridaz-18F positron emission tomography myocardial perfusion imaging: A prespecified subgroup analysis of the AURORA phase 3 study
Krishna K. Patel, Jamshid Maddahi, Denis Agostini, Jeroen Joost Bax, Rob S. Beanlands, Daniel S. Berman, +9 more
2citations -
POSTER: MPN-161: Benefit of Rusfertide Maintained in Patients With Low-Risk or High-Risk Polycythemia Vera: Efficacy and Safety Subgroup Analysis From the Randomized Controlled Phase 3 VERIFY Study2026 Clinical Lymphoma Myeloma & Leukemia article Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment
Naveen Pemmaraju, Valentín García‐Gutiérrez, Aniket Bankar, Kristen Marie Pettit, Joseph Shatzel, Alessandro Lucchesi, +19 more
0citations -
Radar reflectors for marking of target lymph nodes in patients receiving neoadjuvant chemotherapy for breast cancer – a subgroup analysis of the prospective AXSANA (EUBREAST-03) trial2024 Senologie - Zeitschrift für Mammadiagnostik und -therapie article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
Malgorzata Joanna Banys-Paluchowski, Timo Basali, Jana de Boniface, Oreste Gentilini, Elmar Stickeler, Michael Untch, +24 more
0citations -
Ibrutinib and rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisone in patients with previously untreated non‐germinal centre B‐cell‐like diffuse large B‐cell lymphoma: A Chinese subgroup analysis of the phase III PHOENIX trial
Jun Zhu, Xiaonan Hong, Yu Qin Song, Brendan Paul Hodkinson, Sriram Balasubramanian, Songbai Wang, +10 more
7citations -
Enzalutamide with androgen deprivation therapy in Japanese men with metastatic hormone‐sensitive prostate cancer: A subgroup analysis of the phase III ARCHES study2021 International Journal of Urology article Medicine Prostate Cancer Treatment and Research Open access
Taro Iguchi, Go Kimura, Satoshi Fukasawa, Hiroyoshi Suzuki, Hiroji Uemura, Kazuo Nishimura, +9 more
22citations -
Daratumumab plus bortezomib, cyclophosphamide, and dexamethasone in Asian patients with newly diagnosed AL amyloidosis: subgroup analysis of ANDROMEDA2023 Annals of Hematology article Biochemistry, Genetics and Molecular Biology Amyloidosis: Diagnosis, Treatment, Outcomes Open access
Kenshi Suzuki, Ashutosh D. Wechalekar, Kihyun Kım, Chihiro Shimazaki, Jin Seok Kim, Takayuki Ikezoe, +16 more
13citations -
Treatment Goals in Schizophrenia: Subgroup Analysis of a Survey in Matched Physician-Patient Pairs2025 Patient Preference and Adherence article Medicine Schizophrenia research and treatment Open access
Gerhard Gründer, Philipp Bauknecht, Stefanie Schell, Karolina Leopold, Michael Paulzen, Stefan Leucht
0citations -
How good are the outcomes of instrumented debulking operations for symptomatic spinal metastases and how long do they stand? A subgroup analysis in the global spine tumor study group database
Bart P. Depreitere, Federico Ricciardi, Mark P. Arts, Laurent Balabaud, Cody Eric Bünger, Jacob Maciej Buchowski, +17 more
25citations -
Effect of linagliptin, a dipeptidyl peptidase-4 inhibitor, compared with the sulfonylurea glimepiride on cardiovascular outcomes in Asians with type 2 diabetes: subgroup analysis of the randomized CAROLINA® trial
Takashi Kadowaki, Guang Wang, Julio Rosenstock, Daisuke Yabe, Yongde Peng, Keizo Kanasaki, +6 more
16citations